Trial Profile
Zonisamide for fibromyalgia and migraine.
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase IV
Latest Information Update: 03 Jun 2011
Price :
$35
*
At a glance
- Drugs Zonisamide (Primary)
- Indications Fibromyalgia; Migraine
- Focus Therapeutic Use
- 31 May 2011 Status changed from completed to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 12 Nov 2008 Status changed from recruiting to completed according to ClinicalTrials.gov.
- 19 Sep 2006 New trial record.